Skip to main content
. 2022 Jan 10;106(2):486–493. doi: 10.4269/ajtmh.21-0352

Table 2.

Clinical and paraclinical variables and associations with patient status as cases or control subjects, CaledoFaine study, New Caledonia, 2018 to 2019

Variable Control subjects, n (%) Cases, n (%) Total, N P value*
No Yes No Yes
Headache with brutal onset 32 (45.7) 38 (54.3) 4 (10.4) 31 (88.6) 105 < 0.0001
Fever 5 (7.2) 65 (92.8) 2 (5.7) 33 (94.3) 105 1
Fever ≥ 39°C 54 (73.2) 16 (22.8) 14 (40) 21 (60) 105 0.299
Clinical signs of inflammation
 Eye redness 21 (80.0) 14 (20.0) 16 (53.3) 14 (46.6) 105 < 0.0001
 Meningism 68 (97.2) 2 (2.8) 15 (42.9) 20 (57.1) 105 < 0.0001
 Myalgia 30 (42.9) 40 (57.1) 3 (8.6) 32 (91.4) 105 < 0.0001
 All three signs 68 (97.2) 2 (2.8) 20 (57.1) 15 (42.9) 105 < 0.0001
Jaundice 68 (97.2) 2 (2.8) 15 (42.9) 20 (57.1) 105 < 0.0001
Proteinuria or oligo-anuria 34 (48.6) 36 (51.4) 3 (8.6) 32 (91.4) 105 < 0.0001
Hemoptysis/dyspnea 55 (79.6) 15 (21.4) 12 (34.3) 23 (65.7) 105 < 0.0001
Rainfall or flooding 31 (44.3) 39 (55.7) 2 (5.7) 33 (94.3) 105 < 0.0001
Contact with contaminated environment (water and/or soil) 35 (50) 35 (50) 1 (2.9) 34 (97.1) 105 < 0.0001
Presence of rats (home or area) 41 (59.6) 29 (41.4) 2 (5.7) 33 (94.3) 105 < 0.0001
*

Fisher text.